- Even the superficial overview teaser article is much more comprehensive than my review of companies in the field which actually had a slightly different focus.
- It is also more up-to-date.
Reading the article, I am very excited because there are so many interesting companies to be excited about like for example:
Benchling - a company that builds dna managing, and editing software.
GAE Enzymes - a company that wants to make enzymes more rapidly
Glowee - a company that wants to make biological lighting
Gincko Bioworks - a microbe design company
Twist - a DNA synthesis company
One interesting thing was who was not mentioned in the public article: Amyris. I guess this has to do with the fact that Amyris is no longer new and "exciting", but a known quantity. I think this is positive because it means that Amyris is no longer really a start-up company :-) Hopefully, they will be the first to turn profitable to show the rest of the field that it is possible!
I think Todd Slaby, a good friend of mine, put it really nicely when he wrote the following:
Here's an interesting article that just scratches the surface of the landmark shift we are all just beginning to experience in how R&D is organized and leveraged. In many ways, Synthetic Biology isn't a collection of tools as much as it is a mindset that draws heavily from 20th Century Total Quality-inspired approaches to manufacturing. Early adopters intuitively understood that. It's gratifying to see so many others discovering value in it, as well.I recommend that you go over to the article and read it directly!